Hikma Pharmaceuticals PLC (HIK)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
2,146.00p
Buy
2,148.00p
36.00p (+1.70%)
Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.
Prices updated at 28 May 2025, 19:12 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
15 May 202508 May 202508 May 202508 May 202530 Apr 202524 Apr 202524 Apr 202510 Apr 202508 Apr 202501 Apr 2025
Key dates
| Forecast date | |
|---|---|
| Annual general meeting | Apr 2026 |
| Annual report | Mar 2026 |
| Final results | Feb 2026 |
| Half yearly results | Aug 2025 |
| Previous date | |
|---|---|
| Annual general meeting | Apr 2025 |
| Annual report | Mar 2025 |
| Final results | Feb 2025 |
| Half yearly results | Aug 2024 |
Company reports
31 Dec 2023
Annual Report 31 Dec 2023
Quarterly Report 